Sveika ląstelė - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 332,716 | 378,549 | 526,927 | 686,101 | 723,961 | 867,257 | 965,157 | 923,689 |
| Profit before tax | -16,413 | -36,055 | 19,924 | - | - | - | - | - |
| Net profit | -16,413 | -36,055 | 18,671 | -24,696 | -46,726 | -12,587 | 78,741 | 26,988 |
| Equity | -6,574 | -42,629 | -23,958 | -48,654 | -104,750 | -117,337 | -38,596 | -11,608 |
| Liabilities | 135,056 | 200,381 | 251,327 | 385,177 | 398,332 | 401,882 | 438,776 | 387,834 |
| Non-current assets | 12,991 | 20,137 | 12,955 | 10,570 | 10,060 | 7,695 | 6,126 | 5,554 |
| Current assets | 114,544 | 137,178 | 213,842 | 324,055 | 282,400 | 276,377 | 391,936 | 369,561 |
| Total assets | 127,535 | 157,315 | 226,797 | 334,625 | 292,460 | 284,072 | 398,062 | 375,115 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 153,295 | 189,947 | 197,457 |
| Social insurance contributions | - | - | - | - | - | 28,444 | 22,132 | 29,316 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +24.5% | +13.8% | +39.2% | +30.2% | +5.5% | +19.8% | +11.3% | -4.3% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -12.9% | -22.9% | 8.2% | -7.4% | -16.0% | -4.4% | 19.8% | 7.2% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | - | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -4.9% | -9.5% | 3.5% | -3.6% | -6.5% | -1.5% | 8.2% | 2.9% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -4.9% | -9.5% | 3.8% | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | - | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 95,062 | 89,070 | 110,932 | 108,332 | 119,008 | 150,827 | 193,031 | 156,116 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Sveika ląstelė - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-08-19 | 2026-08-19 | 2467.22 |
| 2026-07-19 | 2026-07-20 | 2458.57 |
| 2026-07-16 | 2026-07-17 | 2458.57 |
| 2026-03-29 | 2026-04-01 | 11.86 |
| 2026-03-17 | 2026-03-27 | 11.86 |
| 2025-10-23 | 2025-11-16 | 0.56 |
| 2025-02-18 | 2025-03-13 | 0.01 |
| 2025-01-16 | 2025-02-16 | 0.01 |
| 2024-09-17 | 2024-10-14 | 3.80 |
| 2024-08-19 | 2024-09-12 | 3.80 |
| 2024-07-16 | 2024-08-15 | 3.80 |
| 2024-06-18 | 2024-07-14 | 3.80 |
| 2024-05-16 | 2024-06-16 | 3.80 |
| 2024-04-23 | 2024-05-14 | 3.80 |
| 2024-04-16 | 2024-04-22 | 2.14 |
| 2024-03-18 | 2024-04-14 | 2.14 |
| 2024-01-23 | 2024-03-13 | 2.14 |
| 2024-01-17 | 2024-01-22 | 0.70 |
| 2024-01-16 | 2024-01-16 | 1839.47 |
| 2024-01-15 | 2024-01-15 | 0.70 |
| 2023-12-18 | 2024-01-11 | 0.70 |
| 2023-10-25 | 2023-12-14 | 0.70 |
| 2022-04-28 | 2022-05-15 | 1.02 |
| 2022-01-18 | 2022-02-10 | 0.28 |
| 2021-12-16 | 2022-01-13 | 0.28 |
| 2021-11-16 | 2021-12-14 | 1.81 |
| 2021-11-05 | 2021-11-14 | 1.81 |
| 2021-10-18 | 2021-11-04 | 0.28 |
| 2021-09-16 | 2021-10-14 | 0.28 |
Sveika ląstelė - VMI tax arrears
As of 2026-09-02, the amount of overdue STI tax debt of the company Sveika ląstelė is: 3 €
| From | To | Overdue, € |
|---|---|---|
| 2026-09-01 | 2026-09-02 | 3.24 |
| 2026-08-19 | 2026-08-29 | 1.74 |
| 2026-07-26 | 2026-08-18 | 2.04 |
| 2026-07-02 | 2026-07-07 | 11.97 |
| 2026-06-30 | 2026-07-01 | 8624.07 |
| 2026-06-28 | 2026-06-29 | 8630.0 |
| 2026-06-01 | 2026-06-02 | 9.37 |
| 2026-05-28 | 2026-05-28 | 9143.75 |
| 2026-04-28 | 2026-04-28 | 0.21 |
| 2026-04-01 | 2026-04-27 | 1.21 |
| 2026-03-29 | 2026-03-31 | 0.46 |
| 2026-03-19 | 2026-03-27 | 2.46 |
| 2026-03-02 | 2026-03-12 | 2.46 |
| 2025-09-01 | 2025-09-03 | 5.16 |
| 2025-08-08 | 2025-08-12 | 58.52 |
| 2025-08-07 | 2025-08-07 | 211.41 |
| 2025-07-17 | 2025-08-06 | 10.86 |
| 2025-07-06 | 2025-07-16 | 45.16 |
| 2025-07-05 | 2025-07-05 | 55.56 |
| 2025-07-04 | 2025-07-04 | 55.72 |
| 2025-07-01 | 2025-07-03 | 10.56 |
| 2025-06-28 | 2025-06-28 | 10828.0 |
| 2025-06-19 | 2025-06-20 | 4373.0 |
| 2025-06-14 | 2025-06-18 | 45.0 |
| 2025-05-29 | 2025-06-05 | 8.42 |
| 2025-05-01 | 2025-05-28 | 9.95 |
| 2025-04-28 | 2025-04-28 | 12362.93 |
| 2025-04-02 | 2025-04-10 | 7.78 |
| 2025-03-28 | 2025-04-01 | 3.89 |
| 2025-03-08 | 2025-03-12 | 987.63 |
| 2025-03-02 | 2025-03-07 | 989.07 |
| 2025-02-28 | 2025-03-01 | 960.51 |
| 2025-02-27 | 2025-02-27 | 1.0 |
| 2025-02-02 | 2025-02-17 | 18.13 |
| 2025-01-31 | 2025-02-01 | 14.08 |
| 2024-11-01 | 2024-11-25 | 4.8 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Sveika lastele, UAB (code 125878633) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In 2025, the company generated revenue of €923.7K and net profit of €27.0K, with a profit margin of 2.9%. Revenue declined by 4.3% year on year, although it remained 6.5% above the 2023 level, showing that the business still operated above its recent two-year base. Profitability weakened from the stronger 2024 result, when revenue reached €965.2K and net profit was €78.7K. The 2023 financial year showed €867.3K in revenue and a net loss of €12.6K.
At the end of 2025, total assets amounted to €375.1K, supported by €369.6K of short-term assets and €5.6K of long-term assets. Equity remained negative at €11.6K, while liabilities stood at €387.8K. Asset turnover was 2.46x and return on assets was 7.2%, indicating efficient use of the asset base despite a still fragile capital structure. Revenue per employee was €184.7K and profit per employee was €5.4K.
At the end of 2025, total assets amounted to €375.1K, supported by €369.6K of short-term assets and €5.6K of long-term assets. Equity remained negative at €11.6K, while liabilities stood at €387.8K. Asset turnover was 2.46x and return on assets was 7.2%, indicating efficient use of the asset base despite a still fragile capital structure. Revenue per employee was €184.7K and profit per employee was €5.4K.